Lind;M;Jendle;J;Lager;I.Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction.0.41-41Lind M, Jendle J, Torffvit O, Lager I. Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weig...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that promotes healthy insulin signaling, regulates blood sugar levels, and suppresses appetite. Consequently, numerous GLP-1 receptor (GLP-1R) stimulating drugs have been developed and approved by the US Food and Drug Administration (FDA) ...
Edison, "Novel GLP-1 (glucagon-like pep- tide-1) analogues and insulin in the treatment for Alzheimer's disease and other neurodegenerative diseases," CNS Drugs, vol. 29, no. 12, pp. 1023-1039, 2015.Calsolaro V, Edison P (2015) Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and ...
In addition, glucagon like peptide-1 receptor agonists (GLP-1RAs) can be combined with GLP-1Rs, playing the same role as GLP-1. A variety of GLP-1RAs and analogues, such as exendin-4 and liraglutide, has been used successfully in the treatment of type 2 diabetes mellitus (T2DM) [2]...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are novel drugs approved for diabetes and obesity. They are acknowledged as a major scientific breakthrough. In addition to their metabolic effects, these medications act on other bodily systems involv
Glucagon-like peptide-1 (GLP-1) analogues reduce energy intake and body weight and seem to modulate addictive behaviour. These GLP-1 properties are of major interest in the context of smoking cessation. The aim of this study is to evaluate the GLP-1 analogue dulaglutide as a new therapy ...
1. Glucagon-like peptide-1 (GLP-1) analogues were designed through the modification of the en- zymatic hydrolyzation position. 通过改变胰高血糖素样肽-1(GLP-1)易被酶水解部位,采用Fmoc/t-Bu正交保护固相合成策略,并运用微波照射促进高效快速地合成了抗二肽基肽酶IV(DPPIV)的GLP-1类似物,最后经过反相...
1. Glucagon-like peptide-1 (GLP-1) analogues were designed through the modification of the en- zymatic hydrolyzation position. 通过改变胰高血糖素样肽-1(GLP-1)易被酶水解部位,采用Fmoc/t-Bu正交保护固相合成策略,并运用微波照射促进高效快速地合成了抗二肽基肽酶IV(DPPIV)的GLP-1类似物,最后经过反相...
胰高血糖素样肽-1 1. Glucagon-like peptide-1 (GLP-1) analogues were designed through the modification of the en- zymatic hydrolyzation position. 通过改变胰高血糖素样肽-1(GLP-1)易被酶水解部位,采用Fmoc/t-Bu正交保护固相合成策略,并运用微波照射促进高效快速地合成了抗二肽基肽酶IV(DPPIV)的GLP-1...
胰高血糖素样肽-1 1. Glucagon-like peptide-1 (GLP-1) analogues were designed through the modification of the en- zymatic hydrolyzation position. 通过改变胰高血糖素样肽-1(GLP-1)易被酶水解部位,采用Fmoc/t-Bu正交保护固相合成策略,并运用微波照射促进高效快速地合成了抗二肽基肽酶IV(DPPIV)的GLP-...